Document 0572 DOCN M9620572 TI Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro. DT 9602 AU Dyhr-Mikkelsen H; Kjems J; Department of Molecular Biology, University of Aarhus, Denmark. SO J Biol Chem. 1995 Oct 13;270(41):24060-6. Unique Identifier : AIDSLINE MED/96025786 AB Continuous replication of human immunodeficiency virus type I (HIV-1) requires balanced expression of spliced and nonspliced mRNAs in the cytoplasm. This process is regulated post-transcriptionally by the viral-encoded Rev protein. An important prerequisite for Rev responsiveness is the presence of weak splice sites in the viral mRNA. We have investigated the splicing of the second intron of the HIV-1 Tat/Rev transcript in vitro and show that the 3'-splice site region is responsible for the inefficient splicing of the HIV-1 transcript. In contrast, the HIV-1 5'-splice site is highly functional in combination with a heterologous 3'-splice site. Incubation of the HIV-1 transcript in nuclear extract leads to a rapid accumulation of 50 S nonproductive pre-spliceosome complexes. These complexes contain mainly U1 and U2 small nuclear ribonucleoproteins and are formed independently of the presence of the downstream 3'-splice site. The HIV-1 transcripts, which do proceed through the first splicing step, utilize primarily a uridine as the branch acceptor nucleotide. Sequence comparison with other HIV-1 introns suggests that nucleotides other than adenosines are commonly used as branch points in these viruses. DE Base Sequence Blotting, Northern DNA Primers Gene Products, rev/*BIOSYNTHESIS Gene Products, tat/BIOSYNTHESIS Human HIV-1/*GENETICS/*METABOLISM Molecular Sequence Data Plasmids Restriction Mapping Ribonucleoproteins, Small Nuclear/METABOLISM RNA Precursors/*METABOLISM *RNA Splicing RNA, Messenger/*BIOSYNTHESIS RNA, Small Nuclear/BIOSYNTHESIS Spliceosomes/*METABOLISM Support, Non-U.S. Gov't *Transcription, Genetic JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).